Lupin touched an intraday high of Rs 466 and an intraday low of Rs 454.90. At 15:14 hrs the share was quoting at Rs 454.90, down Rs 8.65, or 1.87%.
The company has launched Fortamet Generic at risk in the US, reports CNBC-TV18.
Fortamet is a USD 70 million diabetes drug. Lupin is currently under litigation with Shionogi & Watson.
It was trading with volumes of 60,879 shares. In the previous trading session, the share closed down 0.95% or Rs 4.45 at Rs 463.55.
| Share Price Movement During The Last 12 Months | ||||
| Period | Price | Latest Price | Gain/Loss (Rs.) | % Gain/Loss |
| 3-Days | 456.55 | 454.90 | -1.65 | -0.36 |
| 5-Days | 469.25 | 454.90 | -14.35 | -3.06 |
| 7-Days | 469.25 | 454.90 | -14.35 | -3.06 |
| 15-Days | 468.90 | 454.90 | -14.00 | -2.99 |
| 1-Month | 465.00 | 454.90 | -10.10 | -2.17 |
| 3-Month | 458.65 | 454.90 | -3.75 | -0.82 |
| 6-Month | 413.60 | 454.90 | 41.30 | 9.99 |
| 9-Month | 463.00 | 454.90 | -8.10 | -1.75 |
| 1-Year | 422.65 | 454.90 | 32.25 | 7.63 |
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
